top of page
  • jschloss69

47% of Brain Tumour Participants still alive

The survival data from our Phase 2 tolerability trial on medicinal cannabis and high-grade gliomas, an aggressive brain tumour found that 47% (n=21) were still alive 2 1/2 years post-trial. This means that the participants were 5-7 years post diagnosis in a disease that has a 6–18-month survival rate. All but 2 of the participants were still taking an oral medicinal cannabis at night before bed. The dose was very low normally of a 1:1 THC to CBD combination. Hopefully more funding can be found to be able to conduct further research in this area.

58 views1 comment

Recent Posts

See All

Hi everyone, it seems that there is some comments on my blog page that are not from me. Please know that I would never put anything inappropriate on my blog and if there is, its not from me. I am unab

Welcome to my new website! there are a couple of exciting new things that are occurring at the moment that may be of interest to you. Launch of a new cooking book called: "Eat for your Life" by Aliso

bottom of page